| The effectiveness of Proctofoam-HC for treatment of hemorrhoids in late pregnancy. | |
| | |
MedLine Citation:
|
PMID: 19761640 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Currently no topical anti-hemorrhoidal agents have been studied for effectiveness in pregnancy. This study evaluated the effectiveness of Proctofoam-HC used during the last trimester of pregnancy. METHODS: In this prospective, open-label, observational study, pregnant women prescribed Proctofoam-HC were asked to complete two telephone interview questionnaires. RESULTS: A total of 88 women completed the study. All hemorrhoidal symptoms, including pain, pruritus, swelling, itching, decreased significantly (P < 0.001) and overall well-being improved. The improvement was clinically very significant after correction for potential placebo effect. CONCLUSIONS: Proctofoam-HC appears to provide effective treatment of hemorrhoids in late pregnancy. |
| | |
Authors:
|
Sabina Vohra; Hani Akoury; Paul Bernstein; Thomas R Einarson; Nicholas Pairaudeau; Anna Taddio; Gideon Koren |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC Volume: 31 ISSN: 1701-2163 ISO Abbreviation: J Obstet Gynaecol Can Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2009-09-18 Completed Date: 2009-10-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101126664 Medline TA: J Obstet Gynaecol Can Country: Canada |
Other Details:
|
Languages: eng Pagination: 654-9 Citation Subset: IM |
Affiliation:
|
The Motherisk Program, Hospital for Sick Children, Toronto, ON, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Topical Adult Anti-Inflammatory Agents / therapeutic use* Drug Combinations Female Hemorrhoids / drug therapy* Humans Hydrocortisone / therapeutic use* Morpholines / therapeutic use* Pregnancy Pregnancy Complications / drug therapy* Prospective Studies |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents; 0/Drug Combinations; 0/Morpholines; 50-23-7/Hydrocortisone; 78457-00-8/proctofoam-HC |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Congenital urethrovaginal fistula with imperforate hymen: a first case report.
Next Document: Policy statement on midwifery.